| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +4,478,699 | 100% | $7.86 | +$35,183,395 |
| Sells | 0 | ||||
| Net | +4 | +4,478,699 | 100% | +$35,183,395 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| JOHN W. CHILDS | Director | $109,167,141 | +$25,996,236 | +31.3% | 13 Nov 2025 |
| Vlad Coric | Chief Executive Officer, Director | $44,663,788 | +$4,999,995 | +12.6% | 13 Nov 2025 |
| Gregory Bailey | Director | $15,150,532 | +$3,000,000 | +24.7% | 13 Nov 2025 |
| Matthew Buten | Chief Financial Officer | $7,474,985 | 05 Jan 2025 | ||
| Kimberly Gentile | SVP, Clinical Operations | $3,777,562 | 05 Jan 2025 | ||
| Bruce Car | Chief Scientific Officer | $1,344,749 | 05 Jan 2025 | ||
| George Clark | VP, Chief Accounting Officer | $1,259,195 | +$144,770 | +13% | 17 Nov 2025 |
| Irina Antonijevic | Director | 05 May 2025 | |||
| JULIA P. GREGORY | Director | 05 May 2025 | |||
| ROBERT J. HUGIN | Director | 05 May 2025 | |||
| Kishan Mehta | Director | 05 May 2025 | |||
| Biohaven Pharmaceutical Holding Co Ltd. | 10%+ Owner | 03 Oct 2022 | |||
| Michael Thomas Heffernan | Director | 05 May 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|